| CMC | carboxymethylcellulose; care management continuity; carpometacarpal; cell-mediated cytolysis or cyto... |
|---|---|
| CMCC | chronic mucocutaneous candidiasis |
| FCMC | familial chronic mucocutaneous candidiasis; family centered maternity care |
| HAM | hearing aid microphone; helical axis in motion; human albumin microsphere; human alveolar macrophage... |
| LAMB | laminin B; lentigines, atrial myxoma, mucocutaneous myxomas, blue nevi [syndrome] |
| CMC | Chronic mucocutaneous candidiasis |
|---|---|
| M.L.N.S. | Mucocutaneous Lymph Node Syndrome |
| MCLS | Mucocutaneous Lymph node Syndrome |
| MCL | Mucocutaneous leishmaniasis |
| candidiasis, chronic mucocutaneous | A clinical syndrome characterised by development, usually in infancy or childhood, of a chronic, often widespread candidiasis of skin, nails, and mucous membranes. It may be secondary to one of the immunodeficiency syndromes, inherited as an autosomal recessive trait, or associated with defects in cell-mediated immunity, endocrine disorders, dental stomatitis, or malignancy. (12 Dec 1998) |
|---|---|
| mucocutaneous | <dermatology> Pertaining to or affecting the mucous membrane and the skin. (18 Nov 1997) |
| mucocutaneous junction | The site of transition from epidermis to the epithelium of a mucous membrane. (05 Mar 2000) |
| mucocutaneous leishmaniasis | A grave disease caused by Leishmania braziliensis braziliensis, endemic in southern Mexico and Central and South America, except for the equatorial region of Chile; the organism does not invade the viscera, and the disease is limited to the skin and mucous membranes, the lesions resembling the sores of cutaneous leishmaniasis caused by L. Mexicana or L. Tropica; the chancrous sores heal after a time, but some months or years later, fungating and eroding forms of ulceration may appear on the tongue and buccal or nasal mucosa; many variants of the disease exist, marked by differences in distribution, vector, epidemiology, and pathology, which suggest that it may in fact be caused by a number of closely related aetiological agents. See: espundia. Synonym: American leishmaniasis, leishmaniasis americana, nasopharyngeal leishmaniasis, New World leishmaniasis. (05 Mar 2000) |
| mucocutaneous lymph node syndrome | <syndrome> An acute febrile illness in children first described in Japan in the late 1960's. Referred to as mucocutaneous lymph node syndrome because of typical changes in the mucus membranes that line the lips and mouth. Enlarged and tender lymph glands are also seen. Synonym:: Kawasaki disease. (13 Nov 1997) |
| mucocutaneous muscle | <anatomy> The "sucking muscle," a labial muscle formed by sagittal fibres running from the skin to the mucous membrane. Synonym: Aeby's muscle, Bovero's muscle, compressor muscle of lips, Klein's muscle, Krause's muscle, mucocutaneous muscle, musculus cutaneomucosus. (05 Mar 2000) |
| syndrome, mucocutaneous lymph node | A syndrome of unknown origin, mainly affecting young children, causing fever, reddening of the eyes more than (conjunctivitis), lips and mucous membranes of the mouth, ulcerative gum disease (gingivitis), swollen glands in the neck (cervical more than lymphadenopathy), and a rash that is raised and bright red (maculoerythematous) in a glove-and-sock fashion over the skin of the hands and feet which becomes hard, swollen (edematous), and peels off. Also called kawasaki's disease. (12 Dec 1998) |
| leishmaniasis, mucocutaneous | A disease characterised by the chronic, progressive spread of lesions from new world cutaneous leishmaniasis caused by species of the l. Braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|